Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis

Suzanne Lentzsch; Galina G. Lagos; Raymond L. Comenzo; Jeffrey A. Zonder; Silva Pregja; Keren Osman; Wei Yann Tsai; Heather Landau; Vaishali Sanchorawala

doi:10.1080/13506129.2019.1583200

Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis

Suzanne Lentzsch, Galina G. Lagos, Raymond L. Comenzo, Jeffrey A. Zonder, Silva Pregja, Keren Osman, Wei Yann Tsai, Heather Landau, Vaishali Sanchorawala

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	113-114
Number of pages	2
Journal	Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Volume	26
Issue number	sup1
DOIs	https://doi.org/10.1080/13506129.2019.1583200
State	Published - 29 Mar 2019

Access to Document

10.1080/13506129.2019.1583200

Cite this

Lentzsch, S., Lagos, G. G., Comenzo, R. L., Zonder, J. A., Pregja, S., Osman, K., Tsai, W. Y., Landau, H., & Sanchorawala, V. (2019). Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 26(sup1), 113-114. https://doi.org/10.1080/13506129.2019.1583200

Lentzsch, Suzanne ; Lagos, Galina G. ; Comenzo, Raymond L. et al. / Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. In: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2019 ; Vol. 26, No. sup1. pp. 113-114.

@article{155224ed720541dc9748a099b633917c,

title = "Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis",

author = "Suzanne Lentzsch and Lagos, {Galina G.} and Comenzo, {Raymond L.} and Zonder, {Jeffrey A.} and Silva Pregja and Keren Osman and Tsai, {Wei Yann} and Heather Landau and Vaishali Sanchorawala",

note = "Funding Information: This study was supported by a grant from Teva Pharmaceutical Industries",

year = "2019",

month = mar,

day = "29",

doi = "10.1080/13506129.2019.1583200",

language = "English",

volume = "26",

pages = "113--114",

journal = "Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis",

issn = "1350-6129",

publisher = "Informa Healthcare",

number = "sup1",

}

Lentzsch, S, Lagos, GG, Comenzo, RL, Zonder, JA, Pregja, S, Osman, K, Tsai, WY, Landau, H & Sanchorawala, V 2019, 'Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis', Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, vol. 26, no. sup1, pp. 113-114. https://doi.org/10.1080/13506129.2019.1583200

Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. / Lentzsch, Suzanne; Lagos, Galina G.; Comenzo, Raymond L. et al.
In: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, Vol. 26, No. sup1, 29.03.2019, p. 113-114.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis

AU - Lentzsch, Suzanne

AU - Lagos, Galina G.

AU - Comenzo, Raymond L.

AU - Zonder, Jeffrey A.

AU - Pregja, Silva

AU - Osman, Keren

AU - Tsai, Wei Yann

AU - Landau, Heather

AU - Sanchorawala, Vaishali

N1 - Funding Information: This study was supported by a grant from Teva Pharmaceutical Industries

PY - 2019/3/29

Y1 - 2019/3/29

UR - http://www.scopus.com/inward/record.url?scp=85069715382&partnerID=8YFLogxK

U2 - 10.1080/13506129.2019.1583200

DO - 10.1080/13506129.2019.1583200

M3 - Letter

C2 - 31343313

AN - SCOPUS:85069715382

SN - 1350-6129

VL - 26

SP - 113

EP - 114

JO - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

JF - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

IS - sup1

ER -

Lentzsch S, Lagos GG, Comenzo RL, Zonder JA, Pregja S, Osman K et al. Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 2019 Mar 29;26(sup1):113-114. doi: 10.1080/13506129.2019.1583200